Zurueck zur Suche

Reporte zur Charge U038864

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

10Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MI 4 NC 1 OR 1 ME 1 PA 1 NY 1 WA 1

VAERS 2647664

MERCK & CO. INC. · ROTAVIRUS (ROTATEQ) · Charge U038864

gering
Staat
NC
Alter
7,0
Geschlecht
F
Eingang
25.05.2023
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
3
Route/Site
PO / MO
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered No adverse event

Symptomtext

No adverse event. Given expired Rotateq vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2616278

MERCK & CO. INC. · ROTAVIRUS (ROTATEQ) · Charge U038864

gering
Staat
OR
Alter
0,5
Geschlecht
F
Eingang
17.04.2023
Impfdatum
05.04.2023
Beginn
05.04.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
PO / MO
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered to patient of inappropriate age

Symptomtext

Rotavirus series started in patient older than 6 months.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2485980

MERCK & CO. INC. · ROTAVIRUS (ROTATEQ) · Charge U038864

gering
Staat
ME
Alter
-
Geschlecht
U
Eingang
22.10.2022
Impfdatum
04.10.2022
Beginn
04.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE reported; ROTATEQ involved in the temperature excursion was administered to the patient; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant medications and drug reactions/ allergies were not reported. On 04-OCT-2022, the patient was vaccinated with an improperly stored (temperature: 47.1 Fahrenheit (F) degrees for 9 hour and 15 minutes and 35.2 F degrees for 45 minutes) rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, at a dose of 2 milliliter, administered orally, lot #U038864 was found to be valid, expiration date: 22-APR-2023 (strength was not reported) for prophylaxis (product storage error). No additional adverse events were reported. There were no previous temperature excursions.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2429374

MERCK & CO. INC. · ROTAVIRUS (ROTATEQ) · Charge U038864

gering
Staat
PA
Alter
0,3
Geschlecht
M
Eingang
06.09.2022
Impfdatum
01.09.2022
Beginn
01.09.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
PO / MO
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Circumstance or information capable of leading to medication error No adverse event Product administered to patient of inappropriate age Wrong product administered

Symptomtext

Patient received Kinrix Dtap + IPV instead of Pediarix vaccine. Nurse misread label and vaccination schedule provided by office. Provider notified, patient's mother notified. No adverse reactions reported. Patient to return in 4 weeks for proper vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Circumstance or information capable of leading to medication error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
NKA
Vorherige Impfungen
-

VAERS 2409001

MERCK & CO. INC. · ROTAVIRUS (ROTATEQ) · Charge U038864

gering
Staat
NY
Alter
-
Geschlecht
M
Eingang
11.08.2022
Impfdatum
05.08.2022
Beginn
06.08.2022
Tage bis Beginn
1,0
Dosis
2
Route/Site
PO / MO
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Abnormal faeces Haematochezia Infant irritability Intussusception Mucous stools Ultrasound scan

Symptomtext

He developed increased fussiness and abnormal stools with blood/mucus. Was instructed to go to the ED. He went to ED and had an US which showed "Self resolving intussusceptions noted during the exam, this is likely intermittent small bowel intussusception. "

Weitere VAERSDATA-Felder
Praegender Schweregrund
Abnormal faeces
Hospital-Tage
-
Labordaten
US done 8/06
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
vitamin D
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2407957

MERCK & CO. INC. · ROTAVIRUS (ROTATEQ) · Charge U038864

gering
Staat
WA
Alter
0,3
Geschlecht
U
Eingang
11.08.2022
Impfdatum
13.07.2022
Beginn
13.07.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No known patient adverse reactions or side effects; 1 dose of ROTATEQ was administered on 7/13/22 / temperature excursion; This spontaneous report was received from an Office Manager/Vaccine Coordinator referring to a 12-week-old patient of unknown gender. The patient's concurrent conditions, medical history, drug reactions/allergies, and concomitant medications were not provided. The Office Manager/Vaccine Coordinator reported that there was a temperature excursion just discovered, it occurred between 11-JUL-2022 and 15-JUL-2022. Vaccines involved in the excursion were Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) and hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (Captured in case # 2208USA003021). The vaccine undergo a temperature excursion of above 47 degrees Fahrenheit (F) (55.2F) for a period of 5 hours, and above 47 degrees Fahrenheit (F) (53F) for a period of 30 minutes (Product storage error). The vaccine did not underwent a previous temperature excursion. On 13-JUL-2022, the patient was vaccinated with a dose of Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) 2ml by mouth, administered as prophylaxis, lot number was verified to be U038864 with expiration date of 22-APR-2023. There were no known patient adverse reactions or side effects (No adverse event). An excursion on 26-JUL-2022 was already reported. This was one of two cases from the same reporter.; Sender's Comments: US-009507513-2208USA003021:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2359165

MERCK & CO. INC. · ROTAVIRUS (ROTATEQ) · Charge U038864

gering
Staat
MI
Alter
-
Geschlecht
U
Eingang
23.07.2022
Impfdatum
29.06.2022
Beginn
29.06.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered Product storage error No adverse event

Symptomtext

Caller reporting a second dose of "not supported" RECOMBIVAX HB vaccine was administered to a patient. She states the "not supported" products were not removed immediately and the patient accidently received another dose; Second "not supported" dose administered: 7/6/2022; First "not supported" dose administered: 6/29/2022; This spontaneous report has been received from a nurse concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions, historical drugs, and concomitant therapies were not reported. On an unspecified date, an hepatitis b vaccine (recombinant) (RECOMBIVAX HB) (lot number W002452 has been verified to be a valid lot number for hepatitis b vaccine (recombinant) (RECOMBIVAX HB), expiration date reported and confirmed as 26-FEB-2024) suffered a temperature excursion of -0.8 Celsius degrees (C) for a time frame of 1 hour 10 minutes. The vaccine had not suffered previous temperature excursions. On 29-JUN-2022, the patient was vaccinated with the first "not supported" dose of hepatitis b vaccine (recombinant) (RECOMBIVAX HB) 0.5 ml (lot number W002452, expiration date 26-FEB-2024) (route of administration and anatomical location were not provided) as prophylaxis (Product storage error). The reporter stated the "not supported" products were not removed immediately and on 06-JUL-2022, the patient accidently received the second "not supported" dose (also reported as "another dose") of hepatitis b vaccine (recombinant) (RECOMBIVAX HB) 0.5 ml (lot number W002452, expiration date 26-FEB-2024) (route of administration and anatomical location were not provided) as prophylaxis (Product storage error) (Extra dose administered).

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2359172

MERCK & CO. INC. · ROTAVIRUS (ROTATEQ) · Charge U038864

gering
Staat
MI
Alter
-
Geschlecht
U
Eingang
06.07.2022
Impfdatum
29.06.2022
Beginn
29.06.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

the patient had no symptoms or adverse events following administration; nurse who reports administration of vaccines following temperature excursion.; This spontaneous report has been received from a nurse referring to a patient of an unknown age and gender. The patient's medical history, concurrent conditions, concomitant medications, and previous drug allergies or reactions were not provided. On 29-JUN-2022, the patient was vaccinated with an improperly stored hepatitis b vaccine (recombinant) (RECOMBIVAX HB) at a dose of 0.5 milliliter once, lot number T032918 was determined to be valid for vial formulation for hepatitis b vaccine (recombinant) (RECOMBIVAX HB), expiration date: 12-NOV-2022 (vaccination scheme, and route of administration were not provided), and rotavirus vaccine, live, oral, pentavalent (ROTATEQ) orally at a dose of 2ml once, lot number U038864, expiration date: 22-APR-2023 (vaccination scheme was not provided), as prophylaxis following a temperature excursion of minus 0.8 degrees Celsius (C) for 1 hour 10 minutes (product storage error), there was stated that no previous temperature excursion occurred. The patient had no symptoms or adverse events following administration of the vaccine. This is one of several cases from the same reporter.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2359169

MERCK & CO. INC. · ROTAVIRUS (ROTATEQ) · Charge U038864

gering
Staat
MI
Alter
-
Geschlecht
U
Eingang
06.07.2022
Impfdatum
29.06.2022
Beginn
29.06.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

the patient had no symptoms or adverse events following administration; nurse who reports administration of vaccines following temperature excursion.; This spontaneous report has been received from a nurse referring to a patient of an unknown age and gender. The patient's medical history, concurrent conditions, concomitant medications, and previous drug allergies or reactions were not provided. On 29-JUN-2022, the patient was vaccinated with an improperly stored hepatitis b vaccine (recombinant) (RECOMBIVAX HB) at a dose of 0.5 milliliter once, lot number T032918 was determined to be valid for vial formulation for hepatitis b vaccine (recombinant) (RECOMBIVAX HB), expiration date: 12-NOV-2022 (vaccination scheme, and route of administration were not provided), and rotavirus vaccine, live, oral, pentavalent (ROTATEQ) orally at a dose of 2ml once, lot number U038864, expiration date: 22-APR-2023 (vaccination scheme was not provided), as prophylaxis following a temperature excursion of minus 0.8 degrees Celsius (C) for 1 hour 10 minutes (product storage error), there was stated that no previous temperature excursion occurred. The patient had no symptoms or adverse events following administration of the vaccine. This is one of several cases from the same reporter.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2359168

MERCK & CO. INC. · ROTAVIRUS (ROTATEQ) · Charge U038864

gering
Staat
MI
Alter
-
Geschlecht
U
Eingang
06.07.2022
Impfdatum
29.06.2022
Beginn
29.06.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

the patient had no symptoms or adverse events following administration; nurse who reports administration of vaccines following temperature excursion.; This spontaneous report has been received from a nurse referring to a patient of an unknown age and gender. The patient's medical history, concurrent conditions, concomitant medications, and previous drug allergies or reactions were not provided. On 29-JUN-2022, the patient was vaccinated with an improperly stored hepatitis b vaccine (recombinant) (RECOMBIVAX HB) at a dose of 0.5 milliliter once, lot number T032918 was determined to be valid for vial formulation for hepatitis b vaccine (recombinant) (RECOMBIVAX HB), expiration date: 12-NOV-2022 (vaccination scheme, and route of administration were not provided), and rotavirus vaccine, live, oral, pentavalent (ROTATEQ) orally at a dose of 2ml once, lot number U038864, expiration date: 22-APR-2023 (vaccination scheme was not provided), as prophylaxis following a temperature excursion of minus 0.8 degrees Celsius (C) for 1 hour 10 minutes (product storage error), there was stated that no previous temperature excursion occurred. The patient had no symptoms or adverse events following administration of the vaccine. This is one of several cases from the same reporter.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-